Tom Isett, iBio CEO

CD­MO makes an AI and drug dis­cov­ery play in lat­est, small-time ac­qui­si­tion

The CD­MO out­fit iBio has net­ted a deal that sees it gain ac­cess to an AI-based plat­form as well as new ther­a­peu­tic can­di­dates as it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.